Involvement of NRON and TUG1 long noncoding RNAs in inflammation and the pathogenesis of EAE

References

• Taghizadeh, E.; Taheri, F.; Samadian, M. M.; Soudyab, M.; Abi, A.; Gheibi Hayat, S. M. Role of Long Non-Coding RNAs (LncRNAs) in Multiple Sclerosis: A Brief Review. Neurol. Sci. 2020, 41, 2443–2451. DOI: 10.1007/s10072-020-04425-2.
   PubMedGoogle Scholar
• Donatelli, S. S.; Zhou, J. M.; Gilvary, D. L.; Eksioglu, E. A.; Chen, X.; Cress, W. D.; Haura, E. B.; Schabath, M. B.; Coppola, D.; Wei, S.; et al. TGF-β-Inducible ­microRNA-183 Silences Tumor-Associated Natural Killer Cells. Proc. Natl. Acad. Sci. U S A 2014, 111, 4203–4208. DOI: 10.1073/pnas.1319269111.
   PubMed Web of Science ®Google Scholar
• Nuzziello, N.; Vilardo, L.; Pelucchi, P.; Consiglio, A.; Liuni, S.; Trojano, M.; Liguori, M. Investigating the Role of MicroRNA and Transcription Factor Co-Regulatory Networks in Multiple Sclerosis Pathogenesis. Int. J. Mol. Sci. 2018, 19, 3652. DOI: 10.3390/ijms19113652.
   PubMed Web of Science ®Google Scholar
• Wan, P.; Su, W.; Zhuo, Y. The Role of Long Noncoding RNAs in Neurodegenerative Diseases. Mol. Neurobiol. 2017, 54, 2012–2021. DOI: 10.1007/s12035-016-9793-6.
   PubMed Web of Science ®Google Scholar
• Dastmalchi, R.; Ghafouri-Fard, S.; Omrani, M. D.; Mazdeh, M.; Sayad, A.; Taheri, M. Dysregulation of Long Non-Coding RNA Profile in Peripheral Blood of Multiple Sclerosis Patients. Mult. Scler. Relat. Disord. 2018, 25, 219–226. DOI: 10.1016/j.msard.2018.07.044.
   PubMedGoogle Scholar
• Sigdel, K. R.; Cheng, A.; Wang, Y.; Duan, L.; Zhang, Y. The Emerging Functions of Long Noncoding RNA in Immune Cells: Autoimmune Diseases. J. Immunol. Res. 2015, 2015, 848790. DOI: 10.1155/2015/848790.
   PubMed Web of Science ®Google Scholar
• Santoro, M.; Nociti, V.; Lucchini, M.; De Fino, C.; Losavio, F. A.; Mirabella, M. Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. J. Mol. Neurosci. 2016, 59, 18–23. DOI: 10.1007/s12031-016-0741-8.
   PubMed Web of Science ®Google Scholar
• Yue, P.; Jing, L.; Zhao, X.; Zhu, H.; Teng, J. Down-Regulation of Taurine-up-Regulated Gene 1 Attenuates Inflammation by Sponging miR-9-5p via Targeting NF-κB1/p50 in Multiple Sclerosis. Life Sci. 2019, 233, 116731. DOI: 10.1016/j.lfs.2019.116731.
   PubMed Web of Science ®Google Scholar
• Kipanyula, M. J.; Kimaro, W. H.; Seke Etet, P. F. The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and Diseases. J. Aging Res. 2016, 2016, 5081021. DOI: 10.1155/2016/5081021.
   PubMedGoogle Scholar
• Fenoglio, C.; Oldoni, E.; Serpente, M.; De Riz, M. A.; Arcaro, M.; D'Anca, M.; Pietroboni, A. M.; Calvi, A.; Lecchi, E.; Goris, A.; et al. LncRNAs Expression Profile in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients. J. Neuroimmunol. 2018, 324, 129–135. DOI: 10.1016/j.jneuroim.2018.08.008.
   PubMed Web of Science ®Google Scholar
• Talebi, F.; Ghorbani, S.; Chan, W. F.; Boghozian, R.; Masoumi, F.; Ghasemi, S.; Vojgani, M.; Power, C.; Noorbakhsh, F. MicroRNA-142 Regulates Inflammation and T Cell Differentiation in an Animal Model of Multiple Sclerosis. J. Neuroinflamm. 2017, 14, 55. DOI: 10.1186/s12974-017-0832-7.
   PubMed Web of Science ®Google Scholar
• Giuliani, F.; Metz, L. M.; Wilson, T.; Fan, Y.; Bar-Or, A.; Yong, V. W. Additive Effect of the Combination of Glatiramer Acetate and Minocycline in a Model of MS. J. Neuroimmunol. 2005, 158, 213–221. DOI: 10.1016/j.jneuroim.2004.09.006.
   PubMed Web of Science ®Google Scholar
• Gresa-Arribas, N.; Viéitez, C.; Dentesano, G.; Serratosa, J.; Saura, J.; Solà, C. Modelling Neuroinflammation in Vitro: A Tool to Test the Potential Neuroprotective Effect of anti-Inflammatory Agents. PLoS One 2012, 7, e45227. DOI: 10.1371/journal.pone.0045227.
   PubMed Web of Science ®Google Scholar
• Amiri, M.; Mokhtari, M. J.; Bayat, M.; Safari, A.; Dianatpuor, M.; Tabrizi, R.; Borhani-Haghighi, A. Expression and Diagnostic Values of MIAT, H19, and NRON Long Non-Coding RNAs in Multiple Sclerosis Patients. Egypt J. Med. Hum. Genet. 2022, 23, 46. DOI: 10.1186/s43042-022-00260-6.
   Google Scholar
• Shan, W.; Chen, W.; Zhao, X.; Pei, A.; Chen, M.; Yu, Y.; Zheng, Y.; Zhu, S. Long Noncoding RNA TUG1 Contributes to Cerebral Ischaemia/Reperfusion Injury by Sponging Mir-145 to up-Regulate AQP4 Expression. J. Cell. Mol. Med. 2020, 24, 250–259. DOI: 10.1111/jcmm.14712.
   PubMed Web of Science ®Google Scholar
• Sharaf-Eldin, W. E.; Kishk, N. A.; Gad, Y. Z.; Hassan, H.; Ali, M. A. M.; Zaki, M. S.; Mohamed, M. R.; Essawi, M. L. Extracellular miR-145, miR-223 and miR-326 Expression Signature Allow for Differential Diagnosis of Immune-Mediated Neuroinflammatory Diseases. J. Neurol. Sci. 2017, 383, 188–198. DOI: 10.1016/j.jns.2017.11.014.
   PubMed Web of Science ®Google Scholar
• Yao, Z.; Xiong, Z.; Li, R.; Liang, H.; Jia, C.; Deng, M. Long Non-Coding RNA NRON is Downregulated in HCC and Suppresses Tumour Cell Proliferation and Metastasis. Biomed. Pharmacother. 2018, 104, 102–109. DOI: 10.1016/j.biopha.2018.05.006.
   PubMed Web of Science ®Google Scholar
• Dietz, L.; Frommer, F.; Vogel, A. L.; Vaeth, M.; Serfling, E.; Waisman, A.; Buttmann, M.; Berberich-Siebelt, F. NFAT1 Deficit and NFAT2 Deficit Attenuate EAE via Different Mechanisms. Eur. J. Immunol. 2015, 45, 1377–1389. DOI: 10.1002/eji.201444638.
   PubMed Web of Science ®Google Scholar
• West, K. A.; Lagos, D. Long Non-Coding RNA Function in CD4+ T Cells: What We Know and What Next? Noncoding RNA 2019, 5, 43. DOI: 10.3390/ncrna5030043.
   PubMed Web of Science ®Google Scholar
• Kunkl, M.; Frascolla, S.; Amormino, C.; Volpe, E.; Tuosto, L. T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis. Cells 2020, 9, 482. DOI: 10.3390/cells9020482.
   PubMed Web of Science ®Google Scholar